STOCK TITAN

Aehr Test Systems 10-Q Filings

AEHR NASDAQ

Every 10-Q that Aehr Test Systems (AEHR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow AEHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AEHR filings page.

Rhea-AI Summary

Aehr Test Systems reported a sharp downturn for the quarter ended February 27, 2026. Revenue fell to $10.3M from $18.3M, a 44% drop, as wafer-level burn-in systems and contactor shipments declined, especially into electric-vehicle power markets.

Gross margin compressed to 32.7% from 39.2%, and the company posted a quarterly net loss of $3.2M versus a $0.6M loss a year earlier. For the first nine months, revenue declined 31% to $31.2M, with a net loss of $8.5M.

Aehr highlighted growing demand for package-level burn-in systems and boards serving AI-related applications and memory, partially offsetting wafer-level weakness. Cash, cash equivalents and restricted cash were $37.1M as of February 27, 2026, supported by $19.6M of net proceeds from common stock sales under its at-the-market offering program.

Rhea-AI Summary

Aehr Test Systems reported weaker results for the quarter ended November 28, 2025. Revenue fell to $9.9 million from $13.5 million, a 27% decline, mainly from lower contactor shipments tied to softness in electric vehicle demand. Six‑month revenue dropped 22% to $20.9 million.

Gross margin compressed to 25.7% from 40.1% as lower production, mix shifts, higher assembly and warranty costs, freight, and tariffs weighed on profitability. Aehr posted a quarterly net loss of $3.2 million, or $0.11 per share, versus a $1.0 million loss a year earlier; six‑month net loss widened to $5.3 million or $0.18 per share.

The company continues to invest in development, with research and development expenses up 31% in the quarter, and is seeing growth in package‑level burn‑in systems and AI‑related applications. Aehr strengthened liquidity by selling 384,380 shares via its ATM program for roughly $10 million of gross proceeds, ending the period with $31.0 million in cash, cash equivalents, and restricted cash and no off‑balance‑sheet debt arrangements disclosed.

Rhea-AI Summary

Aehr Test Systems reported weaker results for the quarter ended August 29, 2025, as demand softened in key markets. Revenue was $10.97 million, down 16% from $13.12 million a year earlier, mainly from a sharp drop in contactor shipments tied to electric vehicle demand.

Gross margin fell to 33.9% from 54.0% due to product mix, higher assembly and warranty costs, tariffs, and amortization of acquired intangibles. The company swung to a net loss of $2.08 million, or $(0.07) per share, compared with net income of $0.66 million, or $0.02 per share, last year.

Operating cash flow was modestly negative at $(0.28) million versus $2.38 million a year earlier. Cash, cash equivalents and restricted cash were $24.66 million at quarter-end. Aehr recorded $0.22 million of restructuring charges from a workforce reduction and recognized a $1.3 million Employee Retention Credit refund in other income. A previously filed shareholder class action and related derivative suits have been dismissed, and a $40 million equity offering program remains unused.